0
SWAB logo

Antibioticagebruik

  1. Oostdijk EA, De Smet AM, Blok HE, Thieme Groen ES, van Asselt GJ, Benus RF, Bernards SA, Frénay IH, Jansz AR, de Jongh BM, Kaan JA, Leverstein-van Hall MA, Mascini EM, Pauw W, Sturm PD, Thijsen SF, Kluytmans JA, Bonten MJ. Ecological Effects of Selective Decontamination on Resistant Gram-negative Bacterial Colonization. Am J Respir Crit Care Med. 2009 Dec 3.
  2. Nijssen S, Fluit A, van de Vijver D, Top J, Willems R, Bonten MJ. Effects of reducing beta-lactam antibiotic pressure on intestinal colonization of antibiotic-resistant gram-negative bacteria.Intensive Care Med. 2009 Nov 18.
  3. Willemsen I, Bogaers-Hofman D, Winters M, Kluytmans J. Correlation between antibiotic use and resistance in a hospital: Temporary and ward-specific observations. Infection. 2009 Oct;37(5):432-7.
  4. Van der Veen EL, Schilder AG, Timmers TK, Rovers MM, Fluit AC, Bonten MJ, Leverstein-van Hall MA. Effect of long-term trimethoprim/sulfamethoxazole treatment on resistance and integron prevalence in the intestinal flora: a randomized, double-blind, placebo-controlled trial in children. J Antimicrob Chemother. 2009 May;63(5):1011-6.
  5. Van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H, Ferech M; European Antimicrobial Resistance Surveillance System Group; European Surveillance of Antimicrobial Consumption Project Group. Antimicrobial drug use and resistance in Europe. Emerg Infect Dis. 2008 Nov;14(11):1722-30.
  6. Akkerman AE, Kuyvenhoven MM, Verheij TJ, van Dijk L. Antibiotics in Dutch general practice: nationwide electronic GP database and national reimbursement rates.Pharmacoepidemiol Drug Saf. 2008 Apr;17(4):378-83.
  7. Visscher S, Schurink CA, Melsen WG, Lucas PJ, Bonten MJ. Effects of systemic antibiotic therapy on bacterial persistence in the respiratory tract of mechanically ventilated patients. Intensive Care Med. 2008 Apr;34(4):692-9.
  8. Grigoryan L, Burgerhof JG, Haaijer-Ruskamp, FM, Degener JE, Deschepper R, Monnet DL, DiMatteo A, Scicluna EA, Bara AC, Lundborg CS, Birkin J, SAR group. Is self-medication with antibiotics in Europe driven by prescribed use? J Antimicrob Chemother 2007;59(1):152-6.
  9. Liem TB, Filius PM, Van der Linden PD, Janknegt R, Natsch S, Vulto AG. Changes in antibiotic use in Dutch hospitals over a six-year period: 1997 to 2002. Neth J Med 2005;63(9):354-60.
  10. Filius PM, Liem TB, Van der Linden PD, Janknegt R, Natsch S, Vulto AG, Verbrugh HA. An additional measure for quantifying antibiotic use in hospitals. J Antimicrob Chemother. 2005;55(5):805-8.
  11. Gyssens IC. Quality measures of antimicrobial drug use. Int J Antimicrob Agents 2001; 17:9-19.
  12. Janknegt R, Oude Lashof A, Gould IM, Van der Meer JWM. Antibiotic Use in Dutch hospitals 1991-1996. Journal of Antimicrobial Chemotherapy (2000) 45, 251-256. Also available through the following links:
    http://jac.oxfordjournals.org/cgi/content/full/45/2/251 (HTML version).
    http://jac.oxfordjournals.org/ (PDF version).
  13. Natsch S, Kullberg BJ, Meis JF, Van der Meer JW. Earlier initiation of antibiotic treatment for severe infecti ons after interventions to improve the organization and specific guidelines in the emergency department. Arch Intern med. 2000 May 8; 160(9);1317-20.
  14. Gyssens IC. How to optimize prescription of antimicrobial drugs. Acta Clin Belg 1999; 54:7-12.
  15. Natsch S, Kullberg BJ, Van der Meer JW, Meis JF. Delay in administering the first dose of antibiotics in patients admitted to hospital with serious infections. Eur J Clin Microbiol Infect Dis.1998 Oct; 17 (10):681-684.
  16. Gyssens IC, Blok WL, Van den Broek PJ, Hekster YA, Van der Meer JW. Implementation of an educational program and an antibiotic order form to optimize quality of antimicrobial drug use in a department of internal medicine. Eur J Clin Microbiol Infect Dis 1997; 16:904-12.